Kathleen D. Scott serves as Executive at Dermata Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Kathleen D. Scott has executed 8 insider transactions totaling $439.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 21, 2025 involved selling 12,500 shares valued at $187.5K.
Kathleen D. Scott currently holds 10,042 shares of Dermata Therapeutics, Inc. (DRMA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kathleen D. Scott has been a net seller of DRMA stock. They have purchased $51.5K and sold $387.5K worth of shares.
Kathleen D. Scott's most recent insider trade was on Aug 21, 2025, when they sold 12,500 shares at $15.00 per share.
Get notified when new Form 4 filings are submitted
| $1.50 |
| Discretionary |
| Aug 20, 2024 | SPRY | $200.0K | Sale | 12,500 | $16.00 | Planned |
| Aug 20, 2024 | SPRY | $18.8K | Option Exercise | 12,500 | $1.50 | Planned |
| Nov 29, 2022 | SPRY | $51.5K | Purchase | 8,250 | $6.24 | Discretionary |
| Oct 6, 2022 | DRMA | $0 | Award | 11,359 | $N/A | Discretionary |
| Jul 7, 2022 | DRMA | $0 | Award | 9,960 | $N/A | Discretionary |
| Apr 7, 2022 | DRMA | $0 | Award | 5,826 | $N/A | Discretionary |